Director TitleAgeSince
Director/Board Member - 01/10/2010
Director/Board Member - 01/10/2010
Change 5-day change 1-year change 3-year change Capi.($)
+179,900.00%-14.29% - - 172K
-0.10%-0.77%+17.58%+70.16% 48.43B
-3.26%-5.31%+53.19%+117.23% 39.72B
-0.60%-0.94%-7.29%+17.35% 12.25B
-2.75%+1.88%+14.81%+76.92% 11.84B
-0.19%-0.38%+30.40%+135.91% 9.06B
+1.56%+5.52%+23.46%+39.78% 7.57B
+0.52%+2.08%+40.75%-12.45% 7.18B
-0.07%+1.72%+13.39%+190.65% 6.84B
-2.51%-3.14%-27.46%+24.20% 5.77B
Average +17,989.26%+1.50%+17.65%+73.31% 16.52B
Weighted average by Cap. -0.97%+1.03%+25.08%+81.16%
Logo Pivotal Therapeutics Inc.
Pivotal Therapeutics Inc is a Canada-based specialty pharmaceutical company with a focus on optimizing Omega-3 therapy for cardiovascular disease and overall health. The Company's lead product VASCAZEN is used to correct an Omega-3 deficiency within eight weeks of treatment with positive concomitant effects on the lipid profiles, mainly a 48% reduction of triglycerides and an increase in high-density lipoprotein- Cholesterol (HDL-C) without a negative impact on the low density lipoprotein cholesterol (LDL-C) lipid profile. Its second product, OMAZEN is a greater than 90% pure, pharmaceutical grade Omega-3 commercialized for sale and distribution in Canada only for the maintenance of health.
Employees
-
  1. Stock Market
  2. Stocks
  3. PVTTF Stock